Jochem Alsenz1, E Haenel. 1. Preclinical Research Department, Pharma Division, F. Hoffmann-La Roche Ltd., CH-4002 Basle, Switzerland. Jochem.Alsenz@roche.com
Abstract
PURPOSE: The aim was to replace the traditional 21-day Caco-2 permeability protocol by a more high-throughput assay. METHODS: Caco-2 cells were seeded at high density in 96-well plates in novel cell culture boxes. After 7 days, drug permeability studies were performed. Samples were analyzed by a new UV detection method. RESULTS: With increased cell seeding density. functional Caco-2 monolayers with polarized efflux transporters were established after 7 days in 96-well polycarbonate filter plates in standard medium. For faster feeding and to eliminate medium replacement in each individual well, plates were completely submerged in medium in novel cell culture boxes, and only medium outside the plate was exchanged. For high-throughput sample analysis, a novel UV-transparent transport buffer was established that allowed direct quantification of permeated drug from its UV absorption. In vitro permeability studies analyzing 22 passively absorbed drugs in the new model correlated well with reported human permeability values (r2 = 0.8725). CONCLUSIONS: The new 7-day. 96-well Caco-2 permeability model tight to UV analysis offers considerable time, cost, and resource savings compared to the traditional model. It has a potential for automation and makes it possible to determine the permeability of passively diffusing compounds and to classify them according to the BCS in a truly medium- to high-throughput mode.
PURPOSE: The aim was to replace the traditional 21-day Caco-2 permeability protocol by a more high-throughput assay. METHODS: Caco-2 cells were seeded at high density in 96-well plates in novel cell culture boxes. After 7 days, drug permeability studies were performed. Samples were analyzed by a new UV detection method. RESULTS: With increased cell seeding density. functional Caco-2 monolayers with polarized efflux transporters were established after 7 days in 96-well polycarbonate filter plates in standard medium. For faster feeding and to eliminate medium replacement in each individual well, plates were completely submerged in medium in novel cell culture boxes, and only medium outside the plate was exchanged. For high-throughput sample analysis, a novel UV-transparent transport buffer was established that allowed direct quantification of permeated drug from its UV absorption. In vitro permeability studies analyzing 22 passively absorbed drugs in the new model correlated well with reported human permeability values (r2 = 0.8725). CONCLUSIONS: The new 7-day. 96-well Caco-2 permeability model tight to UV analysis offers considerable time, cost, and resource savings compared to the traditional model. It has a potential for automation and makes it possible to determine the permeability of passively diffusing compounds and to classify them according to the BCS in a truly medium- to high-throughput mode.
Authors: Duxin Sun; Hans Lennernas; Lynda S Welage; Jeffery L Barnett; Christopher P Landowski; David Foster; David Fleisher; Kyung-Dall Lee; Gordon L Amidon Journal: Pharm Res Date: 2002-10 Impact factor: 4.200
Authors: Christel A S Bergström; Melissa Strafford; Lucia Lazorova; Alex Avdeef; Kristina Luthman; Per Artursson Journal: J Med Chem Date: 2003-02-13 Impact factor: 7.446
Authors: Chong-Hui Gu; Hua Li; Jaquan Levons; Kimberley Lentz; Rajesh B Gandhi; Krishnaswamy Raghavan; Ronald L Smith Journal: Pharm Res Date: 2007-03-24 Impact factor: 4.200